ERS/PATS joint webinar
03 June, 2025 | Online
17:00-18:00 CET

Chairs: Prof. Joy Eze (Enugu, Nigeria), Dr Louisa Pollock (Glasgow, United Kingdom)
Speakers: Dr Moherndran Archary (Durban, South Africa), Prof. Folke Brinkmann (Lübeck, Germany)

Overview

Join us for an insightful webinar that will explore the latest updates in tuberculosis (TB) preventative therapy and treatment regimens, with a focus on both Isoniazid Preventive Therapy (IPT) and treatment approaches for drug-sensitive and multidrug-resistant TB.

This session will provide a comprehensive overview of the recent WHO guidelines, including the introduction of shorter and safer regimens, expanded eligibility criteria, and the importance of systematic screening. Participants will gain valuable insights into the advantages and limitations of short-course TB preventative therapies, strategies for integrating TB and HIV services, and key considerations for drug safety, monitoring, and adherence.

The webinar will also cover the practical and programmatic implications of implementing these new guidelines in diverse healthcare settings, helping healthcare professionals identify eligible patient populations and navigate challenges in delivering effective TB care.

Educational Aims/Learning Outcomes

Following this webinar, participants will be able to:

• Understand the changes in the updated WHO guidelines on TB preventative therapy including shorter regimes, expanded eligibility and emphasis on systematic screening.
• Compare the advantages and limitations of short course TB preventative therapies.
• Appreciate and explain the introduction of shorter and safer TB treatment regimens, both for drug-sensitive and for MDR TB.
• Learn about integration of HIV and primary care services with emphasis on TB/HIV collaborative activities.
• Identify eligible patient populations for the new TB preventative and treatment regimes.
• Be aware of the drug safety, monitoring and adherence strategies.
• Extend your understanding of and discuss the programmatic implications and implementation challenges of the new guidelines.

Topics

• Changes in TB regimens, covering both IPT (Isoniazid Preventive Therapy) and treatment regimes.

Target Audience

• General practitioners, Paediatricians, Paediatric pulmonology fellows, Paediatric pulmonologist, Research nurses, Nurses, Respiratory therapists, Physiotherapists

Format

One-hour webinar format: 45 minutes for presentations, followed by a 15-minute Q&A session.

REGISTER HERE